Ellery Wulczyn

Title: Innovations by Ellery Wulczyn in Prostate Cancer Prediction

Introduction

Ellery Wulczyn is an accomplished inventor based in Mountain View, CA (US). He has made significant contributions to the field of artificial intelligence, particularly in the prediction of prostate cancer outcomes. His innovative approach combines advanced imaging techniques with AI to enhance diagnostic accuracy.

Latest Patents

Ellery Wulczyn holds a patent for an innovative method titled "Artificial intelligence prediction of prostate cancer outcomes." This method involves receiving an image of prostate tissue and assigning Gleason pattern values to specific regions within the image using an AI Gleason grading model. The model is trained to identify Gleason patterns on a patch-by-patch basis. It determines the relative areal proportions of the Gleason patterns within the image and assigns a risk score or risk group value based on these proportions. The output includes at least one of the risk score or risk group value, providing valuable insights for medical professionals.

Career Highlights

Ellery Wulczyn is currently associated with Verily Life Sciences LLC, a company focused on using technology to improve healthcare outcomes. His work at Verily emphasizes the integration of AI in medical diagnostics, showcasing his commitment to advancing healthcare through innovation.

Collaborations

Ellery collaborates with notable colleagues, including Craig Mermel and Yun Liu. Their combined expertise contributes to the development of cutting-edge solutions in the medical field.

Conclusion

Ellery Wulczyn's contributions to artificial intelligence and prostate cancer prediction exemplify the potential of technology in transforming healthcare. His innovative patent and work at Verily Life Sciences LLC highlight the importance of collaboration and advancement in medical diagnostics.